UNCLASSIFIED THERAPEUTIC AGENTS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
OMALIZUMAB: products 1 to 4 of 4.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Omlyclo 150mg/mL Inj Sol-1mL Pref Pen PkDIN 02561026 | Limited Use, codes 726, 727, 728 | $384.9600per source unit | Requirements & sourcesBuild cost plan |
| Omlyclo 150mg/mL Inj Sol-1mL Pref Syr PkDIN 02553813 | Limited Use, codes 726, 727, 728 | $384.9600per source unit | Requirements & sourcesBuild cost plan |
| Omlyclo 75mg/0.5mL Inj Sol-0.5mL Pref Pen PkDIN 02561018 | Limited Use, codes 726, 727, 728 | $168.7440per source unit | Requirements & sourcesBuild cost plan |
| Omlyclo 75mg/0.5mL Inj Sol-0.5mL Pref Syr PkDIN 02553805 | Limited Use, codes 726, 727, 728 | $168.7440per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
92:00 UNCLASSIFIED THERAPEUTIC AGENTS.
92:20 Biologic Response Modifiers.
92:36 Disease-Modifying Antirheumatic Agents.
92:44 Immunosuppressive Agents.
92:92 Other Miscellaneous Therapeutic Agents.